vs
CORCEPT THERAPEUTICS INC（CORT）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
CORCEPT THERAPEUTICS INC的季度营收约是BRC Group Holdings, Inc.的1.1倍（$202.1M vs $188.3M），BRC Group Holdings, Inc.净利率更高（47.9% vs 12.0%，领先35.9%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs -21.9%），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs -15.4%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
CORT vs RILY — 直观对比
营收规模更大
CORT
是对方的1.1倍
$188.3M
营收增速更快
CORT
高出33.0%
-21.9%
净利率更高
RILY
高出35.9%
12.0%
两年增速更快
CORT
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $188.3M |
| 净利润 | $24.3M | $90.3M |
| 毛利率 | 98.7% | 79.5% |
| 营业利润率 | 2.2% | 32.3% |
| 净利率 | 12.0% | 47.9% |
| 营收同比 | 11.1% | -21.9% |
| 净利润同比 | -21.0% | 1710.8% |
| 每股收益（稀释后） | $0.20 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTRILY
| Q4 25 | $202.1M | $188.3M | ||
| Q3 25 | $207.6M | $215.3M | ||
| Q2 25 | $194.4M | $188.2M | ||
| Q1 25 | $157.2M | $197.2M | ||
| Q4 24 | $181.9M | $241.0M | ||
| Q3 24 | $182.5M | $225.5M | ||
| Q2 24 | $163.8M | $256.0M | ||
| Q1 24 | $146.8M | $263.4M |
净利润CORTRILY
| Q4 25 | $24.3M | $90.3M | ||
| Q3 25 | $19.7M | $91.1M | ||
| Q2 25 | $35.1M | $139.5M | ||
| Q1 25 | $20.5M | $-10.0M | ||
| Q4 24 | $30.7M | $-5.6M | ||
| Q3 24 | $47.2M | $-284.4M | ||
| Q2 24 | $35.5M | $-433.6M | ||
| Q1 24 | $27.8M | $-49.2M |
毛利率CORTRILY
| Q4 25 | 98.7% | 79.5% | ||
| Q3 25 | 97.8% | 83.7% | ||
| Q2 25 | 98.2% | 81.3% | ||
| Q1 25 | 98.5% | 81.4% | ||
| Q4 24 | 98.4% | 79.8% | ||
| Q3 24 | 98.4% | 82.1% | ||
| Q2 24 | 98.5% | 84.5% | ||
| Q1 24 | 98.3% | 85.3% |
营业利润率CORTRILY
| Q4 25 | 2.2% | 32.3% | ||
| Q3 25 | 4.9% | 30.4% | ||
| Q2 25 | 13.7% | 5.7% | ||
| Q1 25 | 2.2% | -31.2% | ||
| Q4 24 | 13.9% | -69.2% | ||
| Q3 24 | 25.5% | -36.4% | ||
| Q2 24 | 21.7% | -90.8% | ||
| Q1 24 | 20.1% | -6.1% |
净利率CORTRILY
| Q4 25 | 12.0% | 47.9% | ||
| Q3 25 | 9.5% | 42.3% | ||
| Q2 25 | 18.1% | 74.1% | ||
| Q1 25 | 13.1% | -5.1% | ||
| Q4 24 | 16.9% | -2.3% | ||
| Q3 24 | 25.9% | -126.1% | ||
| Q2 24 | 21.7% | -169.4% | ||
| Q1 24 | 18.9% | -18.7% |
每股收益（稀释后）CORTRILY
| Q4 25 | $0.20 | $2.78 | ||
| Q3 25 | $0.16 | $2.91 | ||
| Q2 25 | $0.29 | $4.50 | ||
| Q1 25 | $0.17 | $-0.39 | ||
| Q4 24 | $0.25 | $-0.01 | ||
| Q3 24 | $0.41 | $-9.39 | ||
| Q2 24 | $0.32 | $-14.35 | ||
| Q1 24 | $0.25 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $647.8M | $-171.5M |
| 总资产 | $836.7M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTRILY
| Q4 25 | $372.2M | $226.6M | ||
| Q3 25 | $421.7M | $184.2M | ||
| Q2 25 | $342.2M | $267.4M | ||
| Q1 25 | $322.8M | $138.3M | ||
| Q4 24 | $383.3M | $146.9M | ||
| Q3 24 | $380.3M | $159.2M | ||
| Q2 24 | $473.2M | $236.9M | ||
| Q1 24 | $410.8M | $190.7M |
总债务CORTRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CORTRILY
| Q4 25 | $647.8M | $-171.5M | ||
| Q3 25 | $631.9M | $-260.5M | ||
| Q2 25 | $635.8M | $-351.7M | ||
| Q1 25 | $683.3M | $-496.8M | ||
| Q4 24 | $679.6M | $-488.2M | ||
| Q3 24 | $638.8M | $-497.6M | ||
| Q2 24 | $596.2M | $-218.3M | ||
| Q1 24 | $547.9M | $228.4M |
总资产CORTRILY
| Q4 25 | $836.7M | $1.7B | ||
| Q3 25 | $823.6M | $1.7B | ||
| Q2 25 | $801.7M | $1.5B | ||
| Q1 25 | $846.5M | $1.5B | ||
| Q4 24 | $840.6M | $1.8B | ||
| Q3 24 | $784.3M | $2.2B | ||
| Q2 24 | $714.6M | $3.2B | ||
| Q1 24 | $655.9M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.58× | 0.29× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CORTRILY
| Q4 25 | $38.4M | $26.2M | ||
| Q3 25 | $54.5M | $-60.6M | ||
| Q2 25 | $43.9M | $-25.6M | ||
| Q1 25 | $5.1M | $184.0K | ||
| Q4 24 | $59.3M | $-2.7M | ||
| Q3 24 | $73.8M | $19.5M | ||
| Q2 24 | $41.2M | $111.5M | ||
| Q1 24 | $23.8M | $135.4M |
自由现金流CORTRILY
| Q4 25 | $38.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $43.9M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $59.2M | — | ||
| Q3 24 | $72.2M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | — | — |
自由现金流率CORTRILY
| Q4 25 | 19.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 39.5% | — | ||
| Q2 24 | 24.9% | — | ||
| Q1 24 | — | — |
资本支出强度CORTRILY
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.0% | — |
现金转化率CORTRILY
| Q4 25 | 1.58× | 0.29× | ||
| Q3 25 | 2.77× | -0.66× | ||
| Q2 25 | 1.25× | -0.18× | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
